Related Experiment Video
Updated: Jun 7, 2025

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
Identification of mild cognitive impairment using multimodal 3D imaging data and graph convolutional networks
Shengbin Liang1, Tingting Chen1, Jinfeng Ma1
1School of Software, Henan University, Kaifeng 475004, People's Republic of China.
Abstract:
Objective.Mild cognitive impairment (MCI) is a precursor stage of dementia characterized by mild cognitive decline in one or more cognitive domains, without meeting the criteria for dementia. MCI is considered a prodromal form of Alzheimer's disease (AD). Early identification of MCI is crucial for both intervention and prevention of AD. To accurately identify MCI, a novel multimodal 3D imaging data integration graph convolutional network (GCN) model is designed in this paper.Approach.The proposed model utilizes 3D-VGGNet to extract three-dimensional features from multimodal imaging data (such as structural magnetic resonance imaging and fluorodeoxyglucose positron emission tomography), which are then fused into feature vectors as the node features of a population graph. Non-imaging features of participants are combined with the multimodal imaging data to construct a population sparse graph. Additionally, in order to optimize the connectivity of the graph, we employed the pairwise attribute estimation (PAE) method to compute the edge weights based on non-imaging data, thereby enhancing the effectiveness of the graph structure. Subsequently, a population-based GCN integrates the structural and functional features of different modal images into the features of each participant for MCI classification.Main results.Experiments on the AD Neuroimaging Initiative demonstrated accuracies of 98.57%, 96.03%, and 96.83% for the normal controls (NC)-early MCI (EMCI), NC-late MCI (LMCI), and EMCI-LMCI classification tasks, respectively. The AUC, specificity, sensitivity, and F1-score are also superior to state-of-the-art models, demonstrating the effectiveness of the proposed model. Furthermore, the proposed model is applied to the ABIDE dataset for autism diagnosis, achieving an accuracy of 91.43% and outperforming the state-of-the-art models, indicating excellent generalization capabilities of the proposed model.Significance.This study demonstratesthe proposed model's ability to integrate multimodal imaging data and its excellent ability to recognize MCI. This will help achieve early warning for AD and intelligent diagnosis of other brain neurodegenerative diseases.
Insights
This study introduces a novel graph convolutional network (GCN) model for early detection of mild cognitive impairment (MCI) using multimodal 3D imaging data. The model achieves high accuracy in classifying MCI, aiding in Alzheimer's disease prediction.
Area of Science:
- Neuroimaging and Artificial Intelligence
- Computational Neuroscience
- Medical Diagnostics
Background:
- Mild cognitive impairment (MCI) is a prodromal stage of dementia and Alzheimer's disease (AD), necessitating early identification for timely intervention.
- Accurate diagnosis of MCI is challenging due to subtle cognitive declines and the need to integrate diverse data sources.
Purpose of the Study:
- To develop and evaluate a novel multimodal 3D imaging data integration graph convolutional network (GCN) model for accurate MCI identification.
- To assess the model's performance in classifying early MCI (EMCI) and late MCI (LMCI) against normal controls (NC).
Main Methods:
- Utilized 3D-VGGNet for feature extraction from multimodal imaging data (sMRI, FDG-PET).
- Constructed a population sparse graph integrating imaging and non-imaging features, optimizing connectivity with pairwise attribute estimation (PAE).
- Employed a population-based GCN to fuse multimodal features for MCI classification.
Main Results:
- Achieved high classification accuracies: 98.57% (NC-EMCI), 96.03% (NC-LMCI), and 96.83% (EMCI-LMCI) on the AD Neuroimaging Initiative dataset.
- Demonstrated superior performance over state-of-the-art models in AUC, specificity, sensitivity, and F1-score.
- Showcased excellent generalization capabilities with 91.43% accuracy for autism diagnosis on the ABIDE dataset.
Conclusions:
- The proposed GCN model effectively integrates multimodal imaging data for robust MCI recognition.
- This approach holds significant potential for early warning of AD and intelligent diagnosis of other neurodegenerative diseases.
- The model's strong performance and generalization highlight its clinical utility in brain disorder diagnostics.

